Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Teleios Health vs Vitara RX

Teleios Health
Graded #328

Lower grade

vs+25.799999999999997
Vitara RX
Graded #16

Higher grade

The verdict

Vitara RX takes it — 86/100 to 60.2/100.

Vitara RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Sub-$100 semaglutide and $149 tirzepatide — both molecules, verified and nationwide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueVitara RX +9
84
93
Dose & formulationVitara RX +16
64
80
Clinical oversightVitara RX +36
49
85
Labs & monitoringVitara RX +35
48
83
FulfillmentVitara RX +45
42
87
Contract termsVitara RX +31
55
86
Teleios Health · left barVitara RX · right bar

The numbers

MetricTeleios HealthVitara RX
WeighScore60.2/10086/100
GradeCB
Scorecard rank#328#16
Semaglutide$99/mo (starting dose, compounded)$99/mo
Tirzepatide$139/mo (starting dose, compounded)$149/mo
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Teleios Health

Graded #328 · C

Strengths

  • Compounded semaglutide from $99/mo — among the lowest floor prices in cash-pay telehealth
  • Compounded tirzepatide from a competitive $139/mo floor
  • Markets physician (MD/DO) prescribing rather than an NP-only model
  • Clean meta-tag and SEO implementation

Where it loses points

  • Single-page app: state availability, pharmacy partner, dose pricing, lab requirements, and refund policy aren't visible and couldn't be verified
  • No named medical director, physician, or corporate entity disclosed
  • Year founded unknown — a newer floor-price entrant warranting extra scrutiny
  • No LegitScript, NABP, or SOC 2 trust signal found
  • Heavy paid-acquisition ad-tech stack — pair with diligence on the clinical layer
Vitara RX

Graded #16 · B

Strengths

  • $99 sema / $149 tirz — bottom-quartile pricing
  • Both molecules, all 50 states
  • LegitScript-verified

Where it loses points

  • Injection-only, no oral route
  • Labs/monitoring not detailed
  • Newer, thinner track record

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard